<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.1//EN" "ep-patent-document-v1-1.dtd">
<ep-patent-document id="EP96922432B8W1" file="EP96922432W1B8.xml" lang="en" country="EP" doc-number="0832271" kind="B8" correction-code="W1" date-publ="20050302" status="c" dtd-version="ep-patent-document-v1-1">
<SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIE......FI......................................</B001EP><B003EP>*</B003EP><B005EP>J</B005EP><B007EP>DIM350 (Ver 2.1 Jan 2001)
 2999001/0</B007EP></eptags></B000><B100><B110>0832271</B110><B120><B121>CORRECTED EUROPEAN PATENT SPECIFICATION</B121></B120><B130>B8</B130><B132EP>B1</B132EP><B140><date>20050302</date></B140><B150><B151>W1</B151><B153>73</B153><B155><B1551>DE</B1551><B1552>Bibliographie</B1552><B1551>EN</B1551><B1552>Bibliography</B1552><B1551>FR</B1551><B1552>Bibliographie</B1552></B155></B150><B190>EP</B190></B100><B200><B210>96922432.8</B210><B220><date>19960606</date></B220><B240><B241><date>19971204</date></B241><B242><date>20000309</date></B242></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>484282</B310><B320><date>19950607</date></B320><B330><ctry>US</ctry></B330><B310>485458</B310><B320><date>19950607</date></B320><B330><ctry>US</ctry></B330></B300><B400><B405><date>20050302</date><bnum>200509</bnum></B405><B430><date>19980401</date><bnum>199814</bnum></B430><B450><date>20041222</date><bnum>200452</bnum></B450><B452EP><date>20040315</date></B452EP><B480><date>20050302</date><bnum>200509</bnum></B480></B400><B500><B510><B516>7</B516><B511> 7C 12N  15/87   A</B511><B512> 7C 12N  15/88   B</B512><B512> 7A 61K  48/00   B</B512><B512> 7A 61K   9/127  B</B512></B510><B540><B541>de</B541><B542>HERSTELLUNG VON LIPID-NUKLEINSÄURE PARTIKELN DUCH EIN HYDROPHOBISCHE LIPID-NUKLEINSÄUREE KOMPLEXE ZWISCHENPRODUKT UND ZUR VERWENDUNG IN DER GENTRANSFER</B542><B541>en</B541><B542>LIPID-NUCLEIC ACID PARTICLES PREPARED VIA A HYDROPHOBIC LIPID-NUCLEIC ACID COMPLEX INTERMEDIATE AND USE FOR GENE TRANSFER</B542><B541>fr</B541><B542>PARTICULES D'ACIDES NUCLEIQUES ET DE LIPIDES PREPAREES AU MOYEN D'UN INTERMEDIAIRE DE COMPLEXE HYDROPHOBE D'ACIDES NUCLEIQUES ET DE LIPIDES ET UTILISATION POUR TRANSFERER DES GENES</B542></B540><B560><B561><text>WO-A-91/16024</text></B561><B561><text>WO-A-93/12240</text></B561><B561><text>WO-A-93/12756</text></B561><B561><text>WO-A-93/24640</text></B561><B561><text>WO-A-93/25673</text></B561><B561><text>WO-A-95/02698</text></B561><B561><text>WO-A-95/18863</text></B561><B561><text>WO-A-95/35301</text></B561><B561><text>WO-A-96/02655</text></B561><B561><text>WO-A-96/10390</text></B561><B561><text>WO-A-96/41873</text></B561><B561><text>US-A- 5 208 036</text></B561><B561><text>US-A- 5 279 833</text></B561><B561><text>US-A- 5 283 185</text></B561><B561><text>US-A- 5 578 475</text></B561><B561><text>US-A- 5 641 662</text></B561><B561><text>US-A- 5 656 743</text></B561><B561><text>US-A- 5 703 055</text></B561><B562><text>R. CORTESI ET AL.: "Effect of cationic liposome composition on in vitro cytotoxicity and protective effect on carried DNA." INTERNATIONAL JOURNAL OF PHARMACEUTICS, vol. 139, no. 1,2, 9 August 1996 (1996-08-09), pages 69-78, XP000874084</text></B562><B562><text>GAY-CAFFEY J K ET AL: "NOVEL POLYAMINOLIPIDS ENHANCE TH CELLULAR UPTAKE OF OLIGONUCLEOTIDES" JOURNAL OF BIOLOGICAL CHEMISTRY,US,AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, vol. 270, no. 52, 29 December 1995 (1995-12-29), pages 31391-31396, XP002017298 ISSN: 0021-9258</text></B562><B562><text>WOUDE VAN DER I ET AL: "PARAMETERS INFLUENCING THE INTRODUCTION OF PLASMID DNA INTO CELLS BY THE USE OF SYNTHETIC AMPHIPHILES AS A CARRIER SYSTEM" BIOCHIMICA ET BIOPHYSICA ACTA. BIOMEMBRANES,NL,AMSTERDAM, vol. 1240, no. 1, 1 January 1995 (1995-01-01), pages 34-40, XP000600703 ISSN: 0005-2736</text></B562><B562><text>DWARKI V J ET AL: "CATIONIC LIPOSOME-MEDIATED RNA TRANSFECTION" METHODS IN ENZYMOLOGY,US,ACADEMIC PRESS INC, SAN DIEGO, CA, vol. 217, 1 January 1993 (1993-01-01), pages 644-654, XP000600710 ISSN: 0076-6879</text></B562><B562><text>FELGNER J ET AL: "CATIONIC LIPID-MEDIATED TRANSFECTION IN MAMMALIAN CELLS: LIPOFECTION" JOURNAL OF TISSUE CULTURE METHODS,NL,KLUWER ACADEMIC PUBLISHERS, AMSTERDAM, vol. 15, no. 2, 1 January 1993 (1993-01-01), pages 63-68, XP000600638 ISSN: 0271-8057</text></B562><B562><text>FELGNER P L ET AL: "CATIONIC LIPOSOME MEDIATED TRANSFECTION" WESTERN PHARMACOLOGY SOCIETY. PROCEEDINGS,US,WESTERN PHARMACOLOGY SOCIETY, TUCSON, AZ, vol. 32, 1 January 1989 (1989-01-01), pages 115-121, XP000196640 ISSN: 0083-8969</text></B562><B562><text>FELGNER J H ET AL: "ENHANCED GENE DELIVERY AND MECHANISM STUDIES WITH A NOVEL SERIES OF CATIONIC LIPID FORMULATIONS" JOURNAL OF BIOLOGICAL CHEMISTRY,US,AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, vol. 269, no. 4, 28 January 1994 (1994-01-28), pages 2550-2561, XP002010485 ISSN: 0021-9258</text></B562></B560></B500><B600><B620EP><parent><cdoc><dnum><anum>04022700.1</anum><pnum>1489184</pnum></dnum><date>20040923</date></cdoc></parent></B620EP></B600><B700><B720><B721><snm>WHEELER, Jeffery, J.</snm><adr><str>306 - 1340 W. 70th Avenue</str><city>Vancouver, British Columbia V6P 2Y8</city><ctry>CA</ctry></adr></B721><B721><snm>BALLY, Marcel, B.</snm><adr><str>SPC 11 Harding Road</str><city>Bowen Island, British Columbia V0N 1G0</city><ctry>CA</ctry></adr></B721><B721><snm>ZHANG, Yuan-Peng</snm><adr><str>Suite 105
40 East 11th Avenue</str><city>Vancouver, British Columbia V5T 2B8</city><ctry>CA</ctry></adr></B721><B721><snm>REIMER, Dorothy, L.</snm><adr><str>Suite 202
55 East 12th Avenue</str><city>Vancouver, British Columbia V5T 4J4</city><ctry>CA</ctry></adr></B721><B721><snm>HOPE, Michael</snm><adr><str>3550 West 11th Avenue</str><city>Vancouver, British Columbia V6R 2K2</city><ctry>CA</ctry></adr></B721><B721><snm>CULLIS, Pieter, R.</snm><adr><str>3732 West 1st Avenue</str><city>Vancouver, British Columbia V6R 1H4</city><ctry>CA</ctry></adr></B721><B721><snm>SCHERRER, Peter</snm><adr><str>Apartment 301
2664 Birch Street</str><city>Vancouver, British Columbia V6H 2T5</city><ctry>CA</ctry></adr></B721></B720><B730><B731><snm>INEX Pharmaceuticals Corp.</snm><iid>01730523</iid><irf>J 2429 - Mr/Sv</irf><syn>Pharmaceuticals Corp., INEX</syn><adr><str>1779 West 75th Avenue</str><city>Vancouver B.C. V6P 6P2</city><ctry>CA</ctry></adr></B731></B730><B740><B741><snm>Finsterwald, Martin</snm><sfx>et al</sfx><iid>00075232</iid><adr><str>Manitz, Finsterwald &amp; Partner GbR
Martin-Greif-Strasse 1</str><city>80336 München</city><ctry>DE</ctry></adr></B741></B740></B700><B800><B840><ctry>AT</ctry><ctry>BE</ctry><ctry>CH</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>IE</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LU</ctry><ctry>MC</ctry><ctry>NL</ctry><ctry>PT</ctry><ctry>SE</ctry></B840><B860><B861><dnum><anum>US1996009949</anum></dnum><date>19960606</date></B861><B862>en</B862></B860><B870><B871><dnum><pnum>WO1996040964</pnum></dnum><date>19961219</date><bnum>199655</bnum></B871></B870><B880><date>19970424</date><bnum>000000</bnum></B880></B800></SDOBI>
</ep-patent-document>
